World’s first anti-ageing gene therapy trial begins as ER-100 is injected into a human eye, testing partial cellular reprogramming to restore vision and fight ageing ...

Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the ...

Aging, at its most fundamental level, is a molecular process. Chemical marks on the genome shift and lose fidelity over time, ...

For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable ...

Butyrate, produced when gut bacteria ferment dietary fiber, was shown to influence immune-cell identity, trafficking, and ...

People with obesity and type 2 diabetes are at high risk of blood vessel damage. This risk depends not only on the genes a ...

Cancer cells are quick to develop resistance to anti-tumor drugs. New research by scientists from the University of ...

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

It may contain inaccuracies due to the limitations of machine translation. Experimental treatment aims to regenerate damaged optic nerves and restore aged cell function in up to 12 patients A U.S.

The first participant has been treated in a landmark clinical trial of cellular reprogramming, which aims to rejuvenate aging ...